These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 24685872)
21. Febuxostat: drug review and update. Grewal HK; Martinez JR; Espinoza LR Expert Opin Drug Metab Toxicol; 2014 May; 10(5):747-58. PubMed ID: 24684266 [TBL] [Abstract][Full Text] [Related]
22. Hypercalcemia worsened by the use of furosemide in a patient suffering from allopurinol-induced granulomatous hepatitis. Hernández LM; Salinas RM; Cabrera MS; Acosta GP; Henríquez MS; Quintana PP; Díaz JG Rev Esp Enferm Dig; 2010 Feb; 102(2):147-8. PubMed ID: 20361854 [No Abstract] [Full Text] [Related]
23. An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study. Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S13-8. PubMed ID: 21654265 [TBL] [Abstract][Full Text] [Related]
24. Allopurinol-induced DRESS syndrome with a histologic pattern consistent with interstitial granulomatous drug reaction. Kim MS; Lee JH; Park K; Son SJ Am J Dermatopathol; 2014 Feb; 36(2):193-6. PubMed ID: 21814129 [No Abstract] [Full Text] [Related]
25. Safety of urate-lowering therapies: managing the risks to gain the benefits. Keenan RT Rheum Dis Clin North Am; 2012 Nov; 38(4):663-80. PubMed ID: 23137576 [TBL] [Abstract][Full Text] [Related]
35. Approach to the treatment of hyperuricemia. Poon SH; Hall HA; Zimmermann B Med Health R I; 2009 Nov; 92(11):359-62. PubMed ID: 19999894 [No Abstract] [Full Text] [Related]
36. Cardiovascular thromboembolic events associated with febuxostat: investigation of cases from the FDA adverse event reporting system database. Gandhi PK; Gentry WM; Bottorff MB Semin Arthritis Rheum; 2013 Jun; 42(6):562-6. PubMed ID: 23352248 [TBL] [Abstract][Full Text] [Related]
37. Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol. Chohan S; Becker MA; MacDonald PA; Chefo S; Jackson RL Arthritis Care Res (Hoboken); 2012 Feb; 64(2):256-61. PubMed ID: 22052584 [TBL] [Abstract][Full Text] [Related]
38. Febuxostat in gout: serum urate response in uric acid overproducers and underexcretors. Goldfarb DS; MacDonald PA; Hunt B; Gunawardhana L J Rheumatol; 2011 Jul; 38(7):1385-9. PubMed ID: 21572152 [TBL] [Abstract][Full Text] [Related]